These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 28388454

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effects of adding cognitive therapy to fluoxetine dose increase on risk of relapse and residual depressive symptoms in continuation treatment of major depressive disorder.
    Perlis RH, Nierenberg AA, Alpert JE, Pava J, Matthews JD, Buchin J, Sickinger AH, Fava M.
    J Clin Psychopharmacol; 2002 Oct; 22(5):474-80. PubMed ID: 12352270
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparative efficacy and durability of continuation phase cognitive therapy for preventing recurrent depression: design of a double-blinded, fluoxetine- and pill placebo-controlled, randomized trial with 2-year follow-up.
    Jarrett RB, Thase ME.
    Contemp Clin Trials; 2010 Jul; 31(4):355-77. PubMed ID: 20451668
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Stable remission and recovery after acute-phase cognitive therapy for recurrent major depressive disorder.
    Vittengl JR, Clark LA, Thase ME, Jarrett RB.
    J Consult Clin Psychol; 2014 Dec; 82(6):1049-59. PubMed ID: 25045908
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cognitive-behavioral therapy to prevent relapse in pediatric responders to pharmacotherapy for major depressive disorder.
    Kennard BD, Emslie GJ, Mayes TL, Nightingale-Teresi J, Nakonezny PA, Hughes JL, Jones JM, Tao R, Stewart SM, Jarrett RB.
    J Am Acad Child Adolesc Psychiatry; 2008 Dec; 47(12):1395-404. PubMed ID: 18978634
    [Abstract] [Full Text] [Related]

  • 13. Quality of life after response to acute-phase cognitive therapy for recurrent depression.
    Vittengl JR, Jha MK, Minhajuddin A, Thase ME, Jarrett RB.
    J Affect Disord; 2021 Jan 01; 278():218-225. PubMed ID: 32971314
    [Abstract] [Full Text] [Related]

  • 14. Cognitive reactivity, dysfunctional attitudes, and depressive relapse and recurrence in cognitive therapy responders.
    Jarrett RB, Minhajuddin A, Borman PD, Dunlap L, Segal ZV, Kidner CL, Friedman ES, Thase ME.
    Behav Res Ther; 2012 May 01; 50(5):280-6. PubMed ID: 22445946
    [Abstract] [Full Text] [Related]

  • 15. Continuation cognitive-behavioural therapy maintains attributional style improvement in depressed patients responding acutely to fluoxetine.
    Petersen T, Harley R, Papakostas GI, Montoya HD, Fava M, Alpert JE.
    Psychol Med; 2004 Apr 01; 34(3):555-61. PubMed ID: 15259840
    [Abstract] [Full Text] [Related]

  • 16. Moderators of continuation phase cognitive therapy's effects on relapse, recurrence, remission, and recovery from depression.
    Vittengl JR, Clark LA, Jarrett RB.
    Behav Res Ther; 2010 Jun 01; 48(6):449-58. PubMed ID: 20163785
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A lifetime approach to major depressive disorder: The contributions of psychological interventions in preventing relapse and recurrence.
    Bockting CL, Hollon SD, Jarrett RB, Kuyken W, Dobson K.
    Clin Psychol Rev; 2015 Nov 01; 41():16-26. PubMed ID: 25754289
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.